Alethia Biotherapeutics Announces Issuance of a Japanese Patent for ... MarketWatch (press release) MONTREAL, QUEBEC, Feb 19, 2013 (MARKETWIRE via COMTEX) -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today that the Company has been ... |
